IP Library Granted Patent US 12,397,067
Granted Patent B2
US 12,397,067 · App. 16/604,531 · Granted Aug 26, 2025

Sulfur- or heavy atom-containing nanoparticles, methods of making same, and uses thereof

Inventors: Ferdinand F.E. Kohle (Tubingen, DE); Joshua A. Hinckley (Ithaca, NY); Nikhil Dhawan (Poughkeepsie, NY); Ulrich B. Wiesner (Ithaca, NY)
Assignee: Cornell University
A61K49/0093A61K47/60A61K47/6923A61K47/6929A61K49/0032G01N21/6458A61K45/06B82Y5/00B82Y30/00B82Y40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,067
App. No.
16/604,531
Granted
Aug 26, 2025
Kind
B2
Abstract

Provided are sulfur- or heavy atom-containing silica or aluminosilica nanoparticles. A nanoparticle can have at least one dye molecule covalently bonded to the silica or aluminosilica matrix of the silica or aluminosilica nanoparticle, respectively. The nanoparticle may have a size, such as, for example, a longest dimension, of less than 10 nm. The silica or aluminosilica nanoparticle can be used in methods such as, for example, imaging methods and photodynamic therapy methods. The imaging methods can provide sub-diffraction limit resolution.

Claims (56)

1. A nanoparticle comprising silica or aluminosilicate; and

5-90 at. % (relative to Si) sulfur atoms covalently bonded to a silica or aluminosilicate network of the nanoparticle; or

1-20 at. % (relative to Si) heavy atoms covalently bonded or non-covalently bonded to a silica or aluminosilicate network of the nanoparticle and/or non-covalently bonded to at least a portion of a surface of the nanoparticle, wherein the heavy atoms are selected from the group consisting of iodine atoms, bromine atoms, and a combination thereof, and the heavy atoms are covalently bonded to the silica or aluminosilicate network of the nanoparticle; or

wherein the heavy atoms are metal ions non-covalently bonded to the silica or aluminosilicate network and/or non-covalently bonded to at least a portion of the surface of the nanoparticle, and the metal ions are selected from the group consisting of gold (Au) ions, silver (Ag) ions, lead (Pb) ions, titanium (Ti) ions, bismuth (Bi) ions, platinum (Pt) ions, indium (In) ions, tin (Sn) ions, antimony (Sb) ions, palladium (Pd) ions, and combinations thereof; and

at least one organic dye molecule, wherein the at least one organic dye molecule is covalently bonded to the silica and/or aluminosilicate network, and at least one polyethylene glycol (PEG) group or moiety covalently bonded to the silica or aluminosilicate network, and wherein the nanoparticle has a longest dimension of 4-9.99 nm.

2. The nanoparticle of claim 1 , wherein the organic dye is a fluorescent dye.

3. The nanoparticle of claim 1 , wherein the organic dye is selected from the group consisting of cyanine dyes, carborhodamine dyes, boron-dipyrromethene (BODIPY) dyes, xanthene dyes, eosins, rhodamines, methylene blue, and derivatives thereof.

4. The nanoparticle of claim 1 , wherein at least a portion of the surface of the nanoparticle is functionalized with polyethylene glycol.

5. The nanoparticle of claim 1 , wherein at least a portion of the surface of the nanoparticle is functionalized with one or more ligands or reactive groups.

6. The nanoparticle of claim 5 , wherein the ligand is selected from the group consisting of biotin, targeting ligands, antibody fragments, glycans, chelator molecules, and drug molecules.

7. A composition comprising a plurality of nanoparticles of claim 1 .

8. The composition of claim 7 , wherein the composition further comprises an aqueous medium and the nanoparticles are present as a dispersion in the aqueous medium.

9. The composition of claim 7 , wherein the composition further comprises a pharmaceutically acceptable carrier.

10. A photodynamic therapy method comprising:

administering to an individual with an abnormal cell a nanoparticle of claim 1 ; and

irradiating the individual or a portion thereof with excitation light, wherein the irradiation results in formation of a reactive ion species.

11. A nanoparticle comprising silica or aluminosilicate; and

1-20 at. % (relative to Si) heavy atoms covalently bonded or non-covalently bonded to a silica or aluminosilicate network of the nanoparticle and/or non-covalently bonded to at least a portion of a surface of the nanoparticle, wherein the heavy atoms are selected from the group consisting of iodine atoms, bromine atoms, metal ions, and a combination thereof, and the metal ions are selected from the group consisting of gold (Au) ions, silver (Ag) ions, lead (Pb) ions, titanium (Ti) ions, bismuth (Bi) ions, platinum (Pt) ions, indium (In) ions, tin (Sn) ions, antimony (Sb) ions, palladium (Pd) ions, and combinations thereof; and

at least one organic dye molecule, wherein the at least one organic dye molecule is covalently bonded to the silica and/or aluminosilicate network, and at least one polyethylene glycol (PEG) group or moiety covalently bonded to the silica or aluminosilicate network, and wherein the nanoparticle has a longest dimension of 4-9.99 nm.

12. A method of making a nanoparticle of claim 11 , comprising:

a) forming a reaction mixture at room temperature comprising: water, tetramethyl orthosilicate (TMOS), an organic dye precursor, a heavy atom-containing precursor, and optionally an alumina-forming precursor; and

b) holding the reaction mixture at a time (t 1 ) and temperature (T 1 ), whereby the nanoparticle is formed.

13. The method of claim 12 , further comprising the steps of:

c) adding at room temperature to the reaction mixture from b) a PEG-silane conjugate and holding the resulting reaction mixture at a time (t 2 ) and temperature (T 2 ); and

d) heating the mixture from c) thereby forming therein.

14. The method of claim 13 , wherein at least a portion of the PEG-silane conjugate comprises a ligand or a reactive group.

15. The method of claim 14 , wherein the PEG-silane conjugate comprising a ligand or a reactive group is added in addition to the PEG-silane conjugate in c), whereby a silica nanoparticle or an aluminosilicate nanoparticle surface functionalized with PEG groups and PEG groups comprising a ligand or a reactive group are formed.

16. The method of claim 13 , wherein before or after the PEG-silane conjugate is added in c) a PEG-silane conjugate comprising a ligand or a reactive group is added at room temperature to the reaction mixture comprising the nanoparticle from b),

holding the resulting reaction mixture at a time (t 4 ) and temperature (T 4 ), and subsequently heating the resulting reaction whereby a nanoparticle surface functionalized with PEG groups comprising a ligand or a reactive group is formed,

optionally, subsequently adding at room temperature to the resulting reaction mixture a PEG-silane conjugate, and holding the resulting reaction mixture at a time (t 6 ) and temperature (T 6 ), and optionally heating the resulting mixture,

whereby nanoparticles surface functionalized with PEG groups and PEG groups comprising a ligand or a reactive group are formed.

17. The method of claim 15 , wherein the nanoparticle is surface functionalized with PEG groups comprising a reactive group, and, the method further comprises reacting the reactive group with a ligand functionalized with a second reactive group, thereby forming a nanoparticle surface functionalized with a ligand.

18. A method of obtaining an image of a sample or a portion thereof, or an image of an individual or a portion thereof, comprising:

contacting the sample or the individual with a nanoparticle of claim 11 ;

irradiating the sample or a portion thereof, or the individual or a portion thereof, with excitation light, thereby exciting the at least one organic dye molecule; and

obtaining a fluorescence image of the sample or portion thereof, or the individual or a portion thereof.

19. A photodynamic therapy method comprising:

administering to an individual with an abnormal cell a nanoparticle of claim 11 ; and

irradiating the individual or a portion thereof with excitation light, wherein the irradiation results in formation of a reactive ion species.

20. A method of making a nanoparticle of claim 1 , comprising:

a) forming a reaction mixture at room temperature comprising: water, tetramethyl orthosilicate (TMOS), an organic dye precursor, a sulfur atom-containing precursor or a heavy atom-containing precursor, and optionally an alumina-forming precursor; and

b) holding the reaction mixture at a time (t1) and temperature (T1), whereby the nanoparticle is formed.

21. The method of claim 20 , further comprising the steps of:

c) adding at room temperature to the reaction mixture from b) a PEG-silane conjugate and holding the resulting reaction mixture at a time (t2) and temperature (T2); and

d) heating the mixture from c) thereby forming therein.

22. The method of claim 21 , wherein at least a portion of the PEG-silane conjugate comprises a ligand or a reactive group.

23. The method of claim 22 , wherein the PEG-silane conjugate comprising a ligand or a reactive group is added in addition to the PEG-silane conjugate in c), whereby a silica nanoparticle or an aluminosilicate nanoparticle surface functionalized with PEG groups and PEG groups comprising a ligand or a reactive group are formed.

24. The method of claim 21 , wherein before or after the PEG-silane conjugate is added in c) a PEG-silane conjugate comprising a ligand or a reactive group is added at room temperature to the reaction mixture comprising the nanoparticle from b ),

holding the resulting reaction mixture at a time (t4) and temperature (T4), and subsequently heating the resulting reaction whereby a nanoparticle surface functionalized with PEG groups comprising a ligand or a reactive group is formed,

optionally, subsequently adding at room temperature to the resulting reaction mixture a PEG-silane conjugate, and holding the resulting reaction mixture at a time (t6) and temperature (T6), and optionally heating the resulting mixture,

whereby nanoparticles surface functionalized with PEG groups and PEG groups comprising a ligand or a reactive group are formed.

25. The method of claim 24 , wherein the nanoparticle is surface functionalized with PEG groups comprising a reactive group, and, the method further comprises reacting the reactive group with a ligand functionalized with a second reactive group, thereby forming a nanoparticle surface functionalized with a ligand.

26. A method of obtaining an image of a sample or a portion thereof, or an image of an individual or a portion thereof, comprising:

contacting the sample or the individual with a nanoparticle of claim 1 ;

irradiating the sample or a portion thereof, or the individual or a portion thereof, with excitation light, thereby exciting the at least one organic dye molecule; and

obtaining a fluorescence image of the sample or portion thereof, or the individual or a portion thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: HINCKLEY, JOSHUA A.; DHAWAN, NIKHIL; WIESNER, ULRICH B.
To: CORNELL UNIVERSITY
Reel/Frame 050916/0235 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: KOHLE, FERDINAND F.E.
To: CORNELL UNIVERSITY
Reel/Frame 050916/0355 →
Continuity (2)
Provisional Application 62483687 · Apr 10, 2017
Related Publication 20200155710A1 · May 21, 2020
References Cited (59)
US 8298677B2 · Wiesner et al. · 2012 [cited by applicant]
US 9625456B2 · Bradbury et al. · 2017 [cited by applicant]
US 11291737B2 · Wiesner et al. · 2022 [cited by applicant]
US 20080063868A1 · Chung et al. · 2008 [cited by applicant]
US 20090101838A1 · Boyden · 2009 [cited by examiner]
US 20100330366A1 · Keiser et al. · 2010 [cited by applicant]
US 20120223273A1 · Wiesner et al. · 2012 [cited by applicant]
US 20120283379A1 · Auger et al. · 2012 [cited by applicant]
US 20130039848A1 · Bradbury · 2013 [cited by applicant]
US 20130064776A1 · El Harrak · 2013 [cited by examiner]
US 20140248210A1 · Bradbury · 2014 [cited by examiner]
US 20150366995A1 · Wiesner · 2015 [cited by applicant]
US 20160018404A1 · Iyer · 2016 [cited by applicant]
US 20160287717A1 · Brinker et al. · 2016 [cited by applicant]
US 20180050115A1 · Mou et al. · 2018 [cited by applicant]
US 20180099050A1 · Trogler et al. · 2018 [cited by applicant]
US 20180133346A1 · Wiesner et al. · 2018 [cited by applicant]
US 20200101180A1 · Bradbury et al. · 2020 [cited by applicant]
US 20200179538A1 · Ma et al. · 2020 [cited by applicant]
CN 102459062A · 2012 [cited by applicant]
CN 107456927A · 2017 [cited by applicant]
CN 105056233B · 2018 [cited by applicant]
EP 2449379B1 · 2017 [cited by applicant]
JP 2009220026A · 2009 [cited by applicant]
JP 2012594014A · 2012 [cited by applicant]
JP 2017031014A · 2017 [cited by applicant]
KR 101622239B1 · 2016 [cited by applicant]
WO 2009029870A2 · 2009 [cited by applicant]
WO 2010121064A2 · 2010 [cited by applicant]
WO 2011003109A1 · 2011 [cited by applicant]
WO WO2011133925A2 · 2011 [cited by examiner]
WO 2013192609A1 · 2013 [cited by applicant]
WO 2014130643A1 · 2014 [cited by applicant]
WO 2016149378A1 · 2016 [cited by applicant]
WO 2016179260A1 · 2016 [cited by applicant]
WO 2017136641A1 · 2017 [cited by applicant]
WO 2018213851A1 · 2018 [cited by applicant]
WO 2018217528A1 · 2018 [cited by applicant]
Benezra et al., Multimodal silica nanoparticles are effective cancer-target probes in a model of human melanoma, Journal of Clinical Investigation, vol. 121, No. 7, pp. 2768-2780 Jul. 1, 2011. [cited by applicant]
Chen et al., Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations, Sep. 15, 2017, vol. 29, pp. 8766-8779. [cited by applicant]
Chen et al., Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma maging, Feb. 7, 2018, vol. 5, No. 10, pp. 4379-4393. [cited by applicant]
International Search Report and Written Opinion of corresponding International Application No. PCT/US2018/026980 filed Apr. 10, 2018, all enclosed pages cited. [cited by applicant]
Lillo et al., Organic-coating of 1-2 nm size silicon nanoparticles: effect on particle properties, Nano Research, vol. 8, No. 6, pp. 2047-2062 Jan. 8, 2015. [cited by applicant]
Ma et al., Ultrasmall Sub-10 nm Near-Infrared Fluorescent Mesoporous Silica Manoparticles, Journal of the American Chemical Society, Jul. 25, 2012, vol. 134, pp. 13180-13183. [cited by applicant]
Ma. K., et al., Controlling Growth of Ultrasmall Sub-10 nm Fluorescent Mesoporous Silica Nanoparticles, Chemistry of Materials, Feb. 11, 2013, vol. 25, pp. 677-691. [cited by applicant]
Ma, K., et al., Control of Ultrasmall Sub-10 nm Ligand-Functionalized Fluorescent Core-Shell Silica Nanoparticle Growth in Water, Chem. Mater., May 13, 2015, vol. 27, May 13, 2015, pp. 4119-4133. [cited by applicant]
Ma et al., Elucidating the Mechanism of Silica Nanoparticle PEGylation Processes Using Flourescence Correlation Spectroscopies, vol. 28, No. 5, pp. 1537-1545 Feb. 8, 2016. [cited by applicant]
Ma et al., Modular and Orthogonal Post-PEGylation Surface Modifications by Insertion Enabling Penta-functional Ultrasmall Organic-Silica Hybrid Nanoparticles, Chemistry of Materials, Jul. 23, 2017, vol. 29, No. 16, pp. … [cited by applicant]
Mendoza, Cornell Prime Dots (C′ dots): Ultrasmall PEDylated Flourescent Core-Shell Silica Nanoparticles for Cancer Theranostics, pp. 1-28 May 1, 2016. [cited by applicant]
Poduval, D.G., On the Role of Acidity in Amorphous Silica-Alumina Based Catalysts, Eindhoven University of lrechnology Library, Thesis, Apr. 5, 2011, 51 pages. [cited by applicant]
Rio-Echevarria et al., Highly PEGylated silica nanoparticles: “ready to use” stealth functional nanocarriers, Journal of Materials Chemistry, vol. 20, No. 14, pp. 2780 Jan. 1, 2010. [cited by applicant]
Santra, et al., “Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers,” Analytical Chemistry, vol. 73, Issue 20 (Sep. 13, 2001), all enclosed pages cited. [cited by applicant]
Schladt, T. D. et al., Multifunctional superparamagnetic MnO@SiO2 core/shell nanoparticles and their application or optical and magnetic resonance imaging, Journal of Materials Chemistry, 2012, vol. 22, pp. 9253-9262. [cited by applicant]
Stöber, et al. “Controlled Growth of Monodisperse Silica Spheres in the Micron Size Range,” Journal of Colloid and Interface Science, 26, (1968), all enclosed pages cited. [cited by applicant]
Sun et al., Water-Based Synthesis of Ultrasmall PEGylated Gold-Silica Core-Shell Nanoparticles with Long-Term Stability, Chemistry of Materials, Sep. 5, 2014, vol. 26, pp. 5201-5207. [cited by applicant]
Yeoh et al., “Preparation and Characterization of Sulpho-functionalized Ordered Mesoporous Silica,” Adsorption Science & Technology, Sep. 1, 2008, pp. 479-489, vol. 26, No. 7. [cited by applicant]
Gobel et al., “Modular Thiol-Ene Chemistry Approach towards Mesoporous Silica Monoliths with Organically Modified Pore Walls,” Chemistry European Journal, Dec. 22, 2014, pp. 17579-17589, vol. 20, Issue 52. [cited by applicant]
Thorat et al., “Synthesis and Stability of IR-820 and FITC Doped Silica Nanoparticles,” Journal of Colloid and Interface Science, Mar. 15, 2017, pp. 294-302, vol. 490. [cited by applicant]
Chang et al., “A Hydrophobic Dye-Encapsulated Nano-Hybrid as an Efficient Fluorescent Probe for Living Cell Imaging,” Advanced Healthcare Materials, Jun. 5, 2012, pp. 475-479 vol. 1, Issue 4. [cited by applicant]